Stock & Company Details
BioAffinity Technologies Inc $BIAF
Price:
N/A
N/A
N/A
$3M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.43
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BIAF technical indicators
Latest BioAffinity Technologies Inc (BIAF) indicator readings as of 2026-08-28.
BIAF's 14-day RSI is 80.2, in overbought territory. At $4.87 it is trading 198.6% above its 200-day moving average of $1.63, and above its 50-day average of $1.11. Price sits near the upper Bollinger Band ($-2.47 to $5.77). ADX reads 55.8, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.
Finance Bot
Ask your questions
Start by typing a question below.
